Last10K.com

Ziopharm Oncology Inc (ZIOP) SEC Filing 8-K Material Event for the period ending Tuesday, October 1, 2019

Ziopharm Oncology Inc

CIK: 1107421 Ticker: ZIOP

View differences made from one to another to evaluate Ziopharm Oncology Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ziopharm Oncology Inc.

Continue

Assess how Ziopharm Oncology Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ziopharm Oncology Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Ziopharm Oncology Inc provided additional information to their SEC Filing as exhibits

Ticker: ZIOP
CIK: 1107421
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-259378
Submitted to the SEC: Tue Oct 01 2019 8:43:06 AM EST
Accepted by the SEC: Tue Oct 01 2019
Period: Tuesday, October 1, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ziop/0001193125-19-259378.htm